Botulinum A toxin
ArticlesRefrigerated StorageLactation Safety InformationNew Medicines · Published , updatedArticles
Safety in Lactation: Antimigraine drugs
If simple analgesics, e.g. paracetamol and ibuprofen, are insufficient to treat symptoms, sumatriptan is the drug of choice for the treatment of acute migraine. Although… Almotriptan Botulinum A toxin Clonidine Eletriptan Ergotamine Frovatriptan Naratriptan Pizotifen Rizatriptan Sumatriptan Tolfenamic acid ZolmitriptanMHRA guidance on Supply and administration of Botox®, Vistabel®, Dysport® and other injectable medicines in cosmetic procedures
As well as covering such questions as who can administer these medicines and who is an appropriate practitioner, this guidance refers to administration of these… Botulinum A toxin Medicines Safety Patient Group Directions RegulatorySafety in Lactation: Drugs for movement disorders
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Drugs for dystonias and other involuntary… Botulinum A toxin Botulinum B toxin Mental health and illness Neurological disorders Obstetrics and gynaecology Orphenadrine Paediatrics and neonates Piracetam Procyclidine Safety in Breastfeeding Tafamidis Tetrabenazine TrihexyphenidylHypersalivation – what are the treatment alternatives to glycopyrronium and hyoscine?
This Medicines Q&A outlines possible alternatives to hyoscine hydrobromide and glycopyrronium in the treatment of non drug-induced hypersalivation, e.g. botulinum toxin, amitriptyline, atropine (eye drops… Administering Amitriptyline Atropine Benzatropine Botulinum A toxin Cisapride Dosing Glycopyrronium Hyoscine (base) Hyoscine hydrobromide Ipratropium Metoprolol Modafinil Neurological disorders Piracetam Propranolol Publications Ranitidine Rotigotine TrihexyphenidylHypersalivation – what drug treatment options are available?
This Medicines Q&A is one of a series of five Q&A documents to address the drug treatment of hypersalivation (drooling or sialorrhoea). It gives a… Amitriptyline Atropine Benzatropine Botulinum A toxin Glycopyrronium Hyoscine hydrobromide Modafinil TrihexyphenidylDrug-induced hypersalivation – what treatment options are available?
This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update… Administering Amisulpride Atropine Benzatropine Biperiden Botulinum A toxin Bupropion Clonidine Clozapine Dosing Glycopyrronium Guanfacine Hyoscine butylbromide Hyoscine hydrobromide Ipratropium Lofexidine Mental Health Mental health and illness Metoclopramide Moclobemide Neurological disorders Oxybutynin Pirenzepine Propantheline Publications Quetiapine Sulpiride Trihexyphenidyl Unlicensed medicinesRefrigerated Storage
Botox
Allergan Ltd.In the event of an inadvertent temperature excursion the following data may be used:
There is no effect on the stability of the product if it was not exposed to temperatures:
Outside a range of -70°C to 30°C for a period of no more than five days (120 hours)
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Dysport
Ipsen Ltd.Contact Ipsen in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Do not freeze
Azzalure
GaldermaIn the event of an inadvertent temperature excursion the following data may be used:
Stability studies have been conducted on unreconstituted Azzalure at 25°C and 40°C for short periods, and these have shown that Azzalure remains stable at 25°C for up to two weeks and at 40°C for up to 24 hours.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk